Welcome

2023 Town and Gown

The MDUK Oxford Neuromuscular Centre surpassed its fundraising goals for the 2023 Town & Gown 10k and had many members participate on race day.

Why we must expand newborn screening

Early diagnosis is of primary importance both to obtain the best effect of innovative medications and to accelerate their development, writes Professor Laurent Servais.

About the Centre

The MDUK Oxford Neuromuscular Centre is a partnership between Muscular Dystrophy UK and the University of Oxford. It was established in January 2019 and aims to drive forward the development of novel experimental therapies and increase national clinical trial capacity in neuromuscular diseases.

MDUK-Oxford University partnership

Changing the landscape for clinical trials by developing a major centre in the UK.

Promising discovery for treatment of neuromuscular diseases

Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy and shows potential for other diseases.

Delivering new experimental medicines and developing enhanced clinical trial capacity in adult and paediatric neuromuscular diseases.

From Centre Director

The MDUK Oxford Neuromuscular Centre represents a very exciting, new opportunity to transform the treatment landscape for neuromuscular diseases. Our aim is to lead innovation throughout the translational pathway from new treatments to innovative new ways of evaluating these in patients with the goal of bringing innovative new treatments to benefit neuromuscular disease patients as quickly as possible.

Please join our efforts!

Professor Matthew Wood